dallas-fort worth lawyers specializing in glp-1 cases Kevin L. Edwards Dallas Personal Injury Lawyer |

Don't for...

While many on the medications said they have changed their lives for the better, some experts are concerned about the long-term effects of these relatively new drugs. Once its approved on the market, theyll collect data for like, a year, and thats it, said Alexis Moore, assistant professor of Physician Assistant studies and a clinician by training

Although present in several plants and extracts, its levels can vary, reflecting differences in plant metabolism, species-specific metabolic pathways, and processing methods

Many therapy areas had high growth in days of therapy in 2023 led by GLP-1 agonists driving obesity and diabetes. As the bar chart clearly tells us from the 3rd line on the bottom of the graph, obesity leads the top 30 therapy areas by growth from 2022

The booming class of GLP-1 drugs that includes Ozempic and Wegovy is also showing early potential to help with Parkinsons disease, a new study suggests.